海普瑞(09989) - 2023 - 中期财报

深圳市海普瑞药业集团股份有限公司 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code 股份代號 : 9989 （於中華人民共和國註冊成立的股份有限公司） | --- | --- | --- | --- | --- | |-------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | 2023 | | | | | | Interim Report 中期報告 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Contents 目錄 Corporate Information 2 公司資料 Finan ...